BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juncal-ruiz M, Riesco-dávila L, Ortiz-garcía de la Foz V, Martínez-garcia O, Ramírez-bonilla M, Ocejo-viñals JG, Leza JC, López-hoyos M, Crespo-facorro B. Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study. Schizophrenia Research 2018;202:226-33. [DOI: 10.1016/j.schres.2018.06.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Strawbridge R, Izurieta E, Day E, Tee H, Young K, Tong CC, Young AH, Cleare AJ. Peripheral inflammatory effects of different interventions for treatment-resistant depression: A systematic review. Neuroscience Applied 2022. [DOI: 10.1016/j.nsa.2022.101014] [Reference Citation Analysis]
2 Liu C, Liu C, Hsieh M, Hwang T, Lin Y, Chien Y, Hwu H. The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114775] [Reference Citation Analysis]
3 Fathian F, Gjestad R, Kroken RA, Løberg E, Reitan SK, Fleichhacker WW, Rettenbacher M, Larsen TK, Joa I, Stabell LA, Kjelby E, Sinkevicute I, Alisauskiene R, Steen VM, Johnsen E. Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis. Schizophrenia Research 2022;241:174-83. [DOI: 10.1016/j.schres.2022.01.049] [Reference Citation Analysis]
4 Kalitin KY, Spasov AA, Mukha OY, Pridvorov GV, Lipatov VA. Pharmacological Targets and Mechanisms of Action of Antipsychotic Substances in the Context of the Neurochemical Theory of the Pathogenesis of Schizophrenia. Neurosci Behav Physi 2022;52:108-123. [DOI: 10.1007/s11055-022-01213-7] [Reference Citation Analysis]
5 Prokopez CR, Farinola R, Vallejos M, Lopredo LS, Sfriso LE, Chiapella LC, Arce C, Corral RM, Cuesta MJ, Alomo M. Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? Schizophrenia Research 2022. [DOI: 10.1016/j.schres.2022.01.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 North HF, Weissleder C, Fullerton JM, Sager R, Webster MJ, Weickert CS. A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone. Transl Psychiatry 2021;11:635. [PMID: 34911938 DOI: 10.1038/s41398-021-01742-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
7 Ganguli S, Chavali PL. Intrauterine Viral Infections: Impact of Inflammation on Fetal Neurodevelopment. Front Neurosci 2021;15:771557. [PMID: 34858132 DOI: 10.3389/fnins.2021.771557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Ozornin AS, Govorin NV, Sakharov AV, Tereshkov PP. [Changes in adipokines in the blood of patients with the first episode of schizophrenia during treatment with haloperidol and risperidone]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:58-62. [PMID: 34693690 DOI: 10.17116/jnevro202112109158] [Reference Citation Analysis]
9 Gasnier M, Ellul P, Plaze M, Ahad PA. A New Look on an Old Issue: Comprehensive Review of Neurotransmitter Studies in Cerebrospinal Fluid of Patients with Schizophrenia and Antipsychotic Effect on Monoamine's Metabolism. Clin Psychopharmacol Neurosci 2021;19:395-410. [PMID: 34294610 DOI: 10.9758/cpn.2021.19.3.395] [Reference Citation Analysis]
10 Marcinowicz P, Więdłocha M, Zborowska N, Dębowska W, Podwalski P, Misiak B, Tyburski E, Szulc A. A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis. J Clin Med 2021;10:2488. [PMID: 34199832 DOI: 10.3390/jcm10112488] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
11 Kim DD, Barr AM, Lian L, Yuen JWY, Fredrikson D, Honer WG, Thornton AE, Procyshyn RM. Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis. NPJ Schizophr 2021;7:29. [PMID: 34035313 DOI: 10.1038/s41537-021-00158-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Jiang P, Sun X, Ren J, Liu H, Lin Z, Liu J, Fang X, Zhang C. Effects of the combination of second-generation antipsychotics on serum concentrations of aripiprazole and dehydroaripiprazole in Chinese patients with schizophrenia. Gen Psychiatr 2021;34:e100423. [PMID: 33851072 DOI: 10.1136/gpsych-2020-100423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Çakici N, Sutterland AL, Penninx BWJH, de Haan L, van Beveren NJM. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Psychol Med 2021;51:538-49. [PMID: 33653423 DOI: 10.1017/S0033291721000155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Crespo-Facorro B, Ruiz-Veguilla M, Vázquez-Bourgon J, Sánchez-Hidalgo AC, Garrido-Torres N, Cisneros JM, Prieto C, Sainz J. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol 2021;12:646701. [PMID: 33762960 DOI: 10.3389/fphar.2021.646701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
15 Jansen van Vuren E, Steyn SF, Brink CB, Möller M, Viljoen FP, Harvey BH. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother 2021;135:111200. [PMID: 33421734 DOI: 10.1016/j.biopha.2020.111200] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 33.0] [Reference Citation Analysis]
16 Pardo-de-Santayana G, Juncal-Ruiz M, Vázquez-Bourgon J, Riesco-Dávila L, Ortiz-Garcia de la Foz V, Pelayo-Terán JM, López-Hoyos M, Crespo-Facorro B. Active psychosis and pro-inflammatory cytokines in first-episode of psychosis. J Psychiatr Res 2021;134:150-7. [PMID: 33385633 DOI: 10.1016/j.jpsychires.2020.12.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Crespo-facorro B, Ruiz-veguilla M, Vázquez-bourgon J, Sánchez-hidalgo AC, Garrido-torres N, Cisneros JM, Prieto C, Sainz J. Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis.. [DOI: 10.1101/2020.12.05.20244590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Juncal-Ruiz M, Riesco-Davila L, Vazquez-Bourgon J, Ortiz-Garcia de la Foz V, Mayoral-Van Son J, Ayesa-Arriola R, Setien-Suero E, Leza JC, Lopez-Hoyos M, Crespo-Facorro B. Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study. Int J Mol Sci 2020;21:E6106. [PMID: 32854231 DOI: 10.3390/ijms21176106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Hill SL, Shao L, Beasley CL. Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder. World J Biol Psychiatry 2021;22:94-103. [PMID: 32295454 DOI: 10.1080/15622975.2020.1755451] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
20 Alvarez-Herrera S, Escamilla R, Medina-Contreras O, Saracco R, Flores Y, Hurtado-Alvarado G, Maldonado-García JL, Becerril-Villanueva E, Pérez-Sánchez G, Pavón L. Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics. Front Endocrinol (Lausanne) 2020;11:195. [PMID: 32373066 DOI: 10.3389/fendo.2020.00195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
21 Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X, Li Z, Yi Z, Geng D. Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology 2020;114:104595. [DOI: 10.1016/j.psyneuen.2020.104595] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
22 Kelsven S, de la Fuente-Sandoval C, Achim CL, Reyes-Madrigal F, Mirzakhanian H, Domingues I, Cadenhead K. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness. Schizophr Res 2020;226:13-23. [PMID: 32089474 DOI: 10.1016/j.schres.2020.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Tendilla-Beltrán H, Meneses-Prado S, Vázquez-Roque RA, Tapia-Rodríguez M, Vázquez-Hernández AJ, Coatl-Cuaya H, Martín-Hernández D, MacDowell KS, Garcés-Ramírez L, Leza JC, Flores G. Risperidone Ameliorates Prefrontal Cortex Neural Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats with Neonatal Ventral Hippocampus Lesion. J Neurosci 2019;39:8584-99. [PMID: 31519825 DOI: 10.1523/JNEUROSCI.1249-19.2019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
24 Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B. Cytokine Research in Depression: Principles, Challenges, and Open Questions. Front Psychiatry 2019;10:30. [PMID: 30792669 DOI: 10.3389/fpsyt.2019.00030] [Cited by in Crossref: 112] [Cited by in F6Publishing: 120] [Article Influence: 37.3] [Reference Citation Analysis]